Andrew Kress, CEO of HealthVerity, emphasized the transformative impact of RWD on clinical trials, stating that access to extensive real-world data allows companies like Recursion to make informed ...

"Our partnership with Recursion underscores the transformative potential of real-world data in driving smarter clinical trials," said Andrew Kress, CEO of HealthVerity.

Instabase, a company that creates software for extracting processing unstructured data from myriad document types, has raised $100m.

The control method of the intelligent manufacturing system proposed in the study is similar to the immune control structure of organisms, and also adopts a recursive control structure. It draws ...

Nvidia-backed Recursion Pharmaceuticals said on Tuesday its experimental drug to treat a rare brain-related condition was safe and tolerable in a mid-stage study, but showed mixed results for ...

Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and ...

SALT LAKE CITY, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced top-line results of ...

Recursion Pharmaceuticals announced results of a clinical trial for its lead drug candidate Tuesday that, while a success on paper, likely won’t satisfy many investors closely watching the AI ...

Bloomberg’s Enterprise Data business produces high-quality pricing, reference and regulatory datasets, real-time market, event and news data, and liquidity analytics along with data management ...

Recursion Pharmaceuticals has a prescription for high drug costs: AI and 25 petabytes of data Growing interest in AI-powered drug discovery draws some big investors–and regulatory questions ...